SENORES PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Senores Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.84₹ -14.75
As on Jan 16, 2026, 4:01 PM IST
Senores Pharmaceuticals Price Performance
Today's LowToday's High
₹786.40₹822.75
₹788.00
52 Weeks' Low52 Weeks' High
₹444.80₹876.00
₹788.00
Open Price
₹822.75
Prev. Close
₹802.75
Volume
9,735
Over the last 5 years, the share price of Senores Pharmaceuticals has gained 7.15% CAGR. Over the past year, the corresponding return has been 67.37%.
Senores Pharmaceuticals’s current P/E of 41.66x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Senores Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Senores Pharmaceuticals | -3.99 | -3.38 | 9.55 | 25.51 | 67.37 | 12.21 | 7.15 |
| Sun Pharmaceutical Industries | -5.24 | -7.12 | 0.92 | -3.39 | -4.99 | 17.25 | 22.54 |
| Divi's Laboratories | -5.49 | -1.78 | -5.14 | -8.17 | 6.06 | 23.21 | 11.34 |
| Torrent Pharmaceuticals | -0.16 | 6.29 | 13.77 | 16.84 | 25.03 | 36.80 | 24.26 |
| Cipla | -4.29 | -7.25 | -10.27 | -6.23 | -3.38 | 9.66 | 11.16 |
| Lupin | -0.74 | 4.02 | 12.03 | 11.42 | 2.16 | 42.16 | 14.74 |
| Dr. Reddy's Laboratories | -2.34 | -7.90 | -4.32 | -6.49 | -11.94 | 10.87 | 2.52 |
| Mankind Pharma | -3.68 | 1.43 | -11.13 | -18.05 | -16.25 | 15.14 | 8.83 |
| Zydus Lifesciences | -4.39 | -5.80 | -11.20 | -10.27 | -11.88 | 25.50 | 12.20 |
| Alkem Laboratories | 0.75 | 3.98 | 4.79 | 18.38 | 12.29 | 24.33 | 13.48 |
| Aurobindo Pharma | -3.29 | -1.55 | 5.22 | 1.31 | 1.72 | 37.78 | 4.51 |
| Abbott India | -1.97 | -0.43 | -6.73 | -19.08 | 0.04 | 8.01 | 13.12 |
| Laurus Labs | -2.23 | 7.17 | 22.93 | 30.14 | 93.28 | 44.84 | 23.83 |
| Biocon | -0.26 | -3.48 | 5.84 | -3.40 | -1.43 | 14.59 | -3.77 |
| Glenmark Pharmaceuticals | -3.74 | 0.77 | 5.68 | -10.16 | 35.45 | 68.26 | 31.32 |
| GlaxoSmithKline Pharmaceuticals | -2.14 | -8.84 | -14.22 | -26.64 | 14.88 | 21.70 | 9.14 |
| Ipca Laboratories | -2.08 | 4.81 | 16.07 | 2.76 | -3.49 | 20.31 | 7.43 |
| Anthem Biosciences | -4.54 | -11.92 | -20.64 | -15.72 | -15.72 | -5.54 | -3.36 |
| Ajanta Pharma | -5.42 | 1.59 | 11.29 | -0.72 | -6.90 | 31.63 | 18.15 |
| Emcure Pharmaceuticals | 2.63 | 11.84 | 14.79 | 14.78 | 14.60 | 4.75 | 2.83 |
Over the last one year, Senores Pharmaceuticals has gained 67.37% compared to peers like Sun Pharmaceutical Industries (-4.99%), Divi's Laboratories (6.06%), Torrent Pharmaceuticals (25.03%). From a 5 year perspective, Senores Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (22.54%) and Divi's Laboratories (11.34%).
Senores Pharmaceuticals Financials
Senores Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 812.12 | 814.42 |
| 10 | 831 | 820.42 |
| 20 | 821.21 | 818.01 |
| 50 | 802.26 | 797.8 |
| 100 | 761.26 | 759.09 |
| 200 | 665.9 | 685.47 |
Senores Pharmaceuticals Share Holding Pattern
In the latest quarter, Senores Pharmaceuticals saw a rise in promoter holding to 45.80%, while DII stake increased to 9.32%, FII holding fell to 3.35%, and public shareholding moved up to 41.54% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Senores Pharmaceuticals Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 6,40,883 | 0.82 | 52.79 | |
| 6,39,101 | 1.88 | 52.64 | |
| 1,07,000 | 0.94 | 8.81 |
* Excluding Index & Arbitrage Funds
Senores Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 15, 2026, 8:14 PM IST | Senores Pharmaceutic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Jan 14, 2026, 12:25 AM IST | Senores Pharmaceutic - Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Fina |
| Jan 12, 2026, 11:21 PM IST | Senores Pharmaceutic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jan 10, 2026, 12:28 AM IST | Senores Pharmaceutic - Notice Of Extra-Ordinary General Meeting Of The Company Scheduled To Be Held On Saturday, January 31, |
| Jan 07, 2026, 11:42 PM IST | Senores Pharmaceutic - Board Meeting Outcome for Outcome Of Board Meeting Held On January 07 ,2026 |
About Senores Pharmaceuticals
Senores Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 26/12/2017 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24290GJ2017PLC100263 and registration number is 100263. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 38.54 Cr. and Equity Capital is Rs. 46.05 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address1101 to 1103, 11th floor, South Tower, Ahmedabad Gujarat 380054
- Contact
Management
- Mr. Sanjay Shaileshbhai MajmudarChairman, Non Ind & Non Exe Director
- Mr. Swapnil Jatinbhai ShahManaging Director
- Mr. Chetan Bipinchandra ShahWhole Time Director & COO
- Mr. Deval Rajnikant ShahWholeTime Director & CFO
- Mr. Hemanshu Nitinchandra PandyaNon Exe.Non Ind.Director
- Mr. Jitendra Babulal SanghviNon Exe.Non Ind.Director
- Mr. Ashokkumar Vijaysinh BarotNon Exe.Non Ind.Director
- Mr. Arpit Deepakkumar ShahNon Exe.Non Ind.Director
- Mr. Kalpit Rajesh GandhiInd. Non-Executive Director
- Mr. Udayan Dileep ChoksiInd. Non-Executive Director
- Mrs. Manjula Devi ShroffInd. Non-Executive Director
- Mr. Naresh Bansilal ShahInd. Non-Executive Director
FAQs on Senores Pharmaceuticals Share Price
What is the share price of Senores Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Senores Pharmaceuticals is ₹788.00 as on Jan 16, 2026.
What kind of stock is Senores Pharmaceuticals?
The Senores Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Senores Pharmaceuticals?
The market cap of Senores Pharmaceuticals is ₹3,629.02 Cr as on Jan 16, 2026.
What are today's High and Low prices of Senores Pharmaceuticals?
Today’s highest and lowest price of Senores Pharmaceuticals are ₹822.75 and ₹786.40.
What are the 52 Week High and 52 Week Low of Senores Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Senores Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Senores Pharmaceuticals is ₹876.00 and 52-week low of Senores Pharmaceuticals is ₹444.80 as on Jan 16, 2026.
How has the Senores Pharmaceuticals performed historically in terms of returns?
The Senores Pharmaceuticals has shown returns of -1.84% over the past day, -3.38% for the past month, 9.55% over 3 months, 67.37% over 1 year, 12.21% across 3 years, and 7.15% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Senores Pharmaceuticals?
P/E ratio of and PB ratio of Senores Pharmaceuticals are 41.66 and 4.46 on Jan 16, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse